Invesco declares quarterly cash distributions for two exchange-traded funds, according to reports. The Invesco Biotechnology & Genome ETF announces a quarterly distribution of $0.8106. Separately, the Invesco Pharmaceuticals ETF announces a quarterly distribution of $0.2733. Both announcements relate to scheduled ETF income distributions to shareholders and indicate the per-share amount expected to be paid for the quarter referenced by each fund’s declaration. The reports do not provide additional operational details in the provided text, such as record dates, payment dates, or distribution frequency beyond the stated “quarterly.” They also do not describe the underlying performance drivers or yield calculations. Overall, the key information common to the sources is that each fund—one focused on biotechnology and genomics and the other on pharmaceuticals—issues a stated cash distribution amount for the current quarter, expressed on a per-share basis.